Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy

BACKGROUND: The prognostic utility of systemic inflammatory markers has so far not been investigated in patients with metastatic testicular germ cell tumours (GCTs). METHODS: International Germ Cell Cancer Cooperative Group (IGCCCG) risk groups and blood-based systemic inflammatory markers (haemoglo...

Descripción completa

Detalles Bibliográficos
Autores principales: Fankhauser, Christian Daniel, Sander, Sophia, Roth, Lisa, Gross, Oliver, Eberli, Daniel, Sulser, Tullio, Seifert, Burkhardt, Beyer, Joerg, Hermanns, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877429/
https://www.ncbi.nlm.nih.gov/pubmed/29485982
http://dx.doi.org/10.1038/bjc.2017.467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877429/
https://www.ncbi.nlm.nih.gov/pubmed/29485982
http://dx.doi.org/10.1038/bjc.2017.467

Ejemplares similares